ID16266A - Perlakuan dan pencegahan pankreatitis - Google Patents

Perlakuan dan pencegahan pankreatitis

Info

Publication number: ID16266A
Authority: ID; Indonesia
Prior art keywords: prevention; treatment; pancreatitical; troglitazone; pancreatitis
Prior art date: 1996-03-18

Application number

IDP970826A

Other languages

English (en)

Indonesian (id)

Inventor

Toshihiko Fujiwara

Hiroyoshi Horikoshi

Masaharu Fukami

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-18

Filing date

1997-03-14

Publication date

1997-09-18

1997-03-14 Application filed by Sankyo Co filed Critical Sankyo Co

1997-09-18 Publication of ID16266A publication Critical patent/ID16266A/id

Links

230000002265 prevention Effects 0.000 title abstract 2
229940122355 Insulin sensitizer Drugs 0.000 abstract 1
206010033645 Pancreatitis Diseases 0.000 abstract 1
150000001467 thiazolidinediones Chemical class 0.000 abstract 1
-1 troglitazone Chemical class 0.000 abstract 1
GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 abstract 1
229960001641 troglitazone Drugs 0.000 abstract 1
GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Catching Or Destruction (AREA)
Superconductors And Manufacturing Methods Therefor (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IDP970826A 1996-03-18 1997-03-14 Perlakuan dan pencegahan pankreatitis ID16266A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP6106396		1996-03-18
JP25020196		1996-09-20

Publications (1)

Publication Number	Publication Date
ID16266A true ID16266A (id)	1997-09-18

Family

ID=26402115

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP970826A ID16266A (id)	1996-03-18	1997-03-14	Perlakuan dan pencegahan pankreatitis

Country Status (18)

Country	Link
US (1)	US5753681A (de)
EP (1)	EP0796618B1 (de)
KR (1)	KR100542778B1 (de)
CN (1)	CN1178657C (de)
AT (1)	ATE212548T1 (de)
AU (1)	AU708315B2 (de)
CA (1)	CA2200126C (de)
CZ (1)	CZ283968B6 (de)
DE (1)	DE69710111T2 (de)
DK (1)	DK0796618T3 (de)
ES (1)	ES2167678T3 (de)
HU (1)	HUP9700598A3 (de)
ID (1)	ID16266A (de)
IL (1)	IL120443A (de)
NO (1)	NO313179B1 (de)
NZ (1)	NZ314406A (de)
PT (1)	PT796618E (de)
TW (1)	TW548102B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9711683D0 (en) *	1997-06-05	1997-08-06	Smithkline Beecham Plc	Composition
KR100666887B1 (ko)	1997-10-08	2007-01-10	상꾜 가부시키가이샤	치환 축합 복소환 화합물
CZ296507B6 (cs)	1998-03-30	2006-03-15	Japan Tobacco Inc.	Zpusob výroby oxazolylethanolových derivátu
US6417185B1 (en)	1998-06-19	2002-07-09	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
ES2237929T3 (es) *	1998-07-21	2005-08-01	Smithkline Beecham Plc	Uso del activador de la asimilacion de glucosa rosiglitazona para reducir la apoptosis inducida por isquemia de celulas beta pancreaticas, celulas endoteliales y celulas neuronales.
US20040102486A1 (en) *	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
US20030153607A1 (en) *	1998-11-12	2003-08-14	Smithkline Beecham P.L.C.	Novel composition and use
CA2369839A1 (en) *	1999-06-25	2001-01-04	Minimed, Inc.	Compositions of insulin and insulin-related peptide for treating diabetes
WO2001014351A1 (en)	1999-08-23	2001-03-01	Kyorin Pharmaceutical Co., Ltd.	Substituted benzylthiazolidine-2,4-dione derivatives
WO2001014349A1 (en)	1999-08-23	2001-03-01	Kyorin Pharmaceutical Co., Ltd.	Substituted benzylthiazolidine-2,4-dione derivatives
US6452014B1 (en) *	2000-12-22	2002-09-17	Geron Corporation	Telomerase inhibitors and methods of their use
AU2002248464A1 (en)	2001-02-21	2002-09-12	Medtronic Minimed, Inc.	Stabilized insulin formulations
US6737401B2 (en)	2001-06-28	2004-05-18	Metronic Minimed, Inc.	Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
SG174891A1 (en)	2009-04-01	2011-11-28	Genentech Inc	Treatment of insulin-resistant disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5522636A (en) *	1978-08-04	1980-02-18	Takeda Chem Ind Ltd	Thiazoliding derivative
JPS6051189A (ja) *	1983-08-30	1985-03-22	Sankyo Co Ltd	チアゾリジン誘導体およびその製造法
DE3343141A1 (de) *	1983-11-29	1985-06-05	Hermann P.T. 7400 Tübingen Ammon	Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
CN1003445B (zh) *	1984-10-03	1989-03-01	武田药品工业株式会社	噻唑烷二酮衍生物，其制备方法和用途
AR240698A1 (es) *	1985-01-19	1990-09-28	Takeda Chemical Industries Ltd	Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
WO1986007056A1 (en) *	1985-05-21	1986-12-04	Pfizer Inc.	Hypoglycemic thiazolidinediones
US5194443A (en) *	1987-09-04	1993-03-16	Beecham Group P.L.C.	Compounds
US5260445A (en) *	1987-09-04	1993-11-09	Beecham Group P.L.C.	2,4-thiazolidinediones
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
US5232925A (en) *	1987-09-04	1993-08-03	Beecham Group P.L.C.	Compounds
MX15171A (es) *	1988-03-08	1993-05-01	Pfizer	Derivados de tiazolidinodiona hipoglicemicos
NO893088L (no) *	1988-08-18	1990-02-19	Syntex Inc	Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
JP2845743B2 (ja) *	1992-12-28	1999-01-13	三菱化学株式会社	新規なナフタレン誘導体
WO1995002340A1 (en) *	1993-07-13	1995-01-26	Moizis Janica M	Fastener for clothing
US5728720A (en) *	1993-12-27	1998-03-17	Japan Tobacco Inc.	Isoxazolidinedione compounds and use thereof
CZ289317B6 (cs) *	1994-04-11	2002-01-16	Sankyo Company Limited	Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
US5594015A (en) *	1994-06-22	1997-01-14	Regents Of The University Of California	Thiazolidine derivatives for the treatment of psoriasis
FR2721608B1 (fr) *	1994-06-22	1996-07-19	Rhone Poulenc Rorer Sa	Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
US5703096A (en) *	1994-10-07	1997-12-30	Sankyo Company, Limited	Oxime derivatives, their preparation and their therapeutic use
CZ293016B6 (cs) *	1995-06-01	2004-01-14	Sankyo Company Limited	Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem

1997
- 1997-03-13 IL IL12044397A patent/IL120443A/xx not_active IP Right Cessation
- 1997-03-13 NZ NZ314406A patent/NZ314406A/xx unknown
- 1997-03-14 CZ CZ97790A patent/CZ283968B6/cs unknown
- 1997-03-14 ID IDP970826A patent/ID16266A/id unknown
- 1997-03-17 EP EP97301773A patent/EP0796618B1/de not_active Expired - Lifetime
- 1997-03-17 ES ES97301773T patent/ES2167678T3/es not_active Expired - Lifetime
- 1997-03-17 DK DK97301773T patent/DK0796618T3/da active
- 1997-03-17 HU HU9700598A patent/HUP9700598A3/hu unknown
- 1997-03-17 PT PT97301773T patent/PT796618E/pt unknown
- 1997-03-17 TW TW086103285A patent/TW548102B/zh not_active IP Right Cessation
- 1997-03-17 US US08/819,686 patent/US5753681A/en not_active Expired - Fee Related
- 1997-03-17 DE DE69710111T patent/DE69710111T2/de not_active Expired - Fee Related
- 1997-03-17 NO NO19971219A patent/NO313179B1/no unknown
- 1997-03-17 AT AT97301773T patent/ATE212548T1/de not_active IP Right Cessation
- 1997-03-17 CA CA002200126A patent/CA2200126C/en not_active Expired - Fee Related
- 1997-03-17 AU AU16285/97A patent/AU708315B2/en not_active Ceased
- 1997-03-18 CN CNB971112118A patent/CN1178657C/zh not_active Expired - Fee Related
- 1997-03-18 KR KR1019970009207A patent/KR100542778B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2200126A1 (en)	1997-09-18
CN1178657C (zh)	2004-12-08
US5753681A (en)	1998-05-19
HU9700598D0 (en)	1997-05-28
EP0796618A1 (de)	1997-09-24
ES2167678T3 (es)	2002-05-16
DE69710111T2 (de)	2002-10-02
MX9702058A (es)	1998-03-31
IL120443A0 (en)	1997-07-13
PT796618E (pt)	2002-06-28
HK1003051A1 (en)	1998-10-09
DE69710111D1 (de)	2002-03-14
DK0796618T3 (da)	2002-05-06
CN1170575A (zh)	1998-01-21
NO971219L (no)	1997-09-19
AU708315B2 (en)	1999-07-29
NZ314406A (en)	2000-12-22
CZ79097A3 (en)	1997-10-15
ATE212548T1 (de)	2002-02-15
IL120443A (en)	2000-07-16
CA2200126C (en)	2006-08-15
HUP9700598A3 (en)	1998-10-28
TW548102B (en)	2003-08-21
NO971219D0 (no)	1997-03-17
KR100542778B1 (ko)	2006-04-14
HUP9700598A2 (hu)	1998-09-28
NO313179B1 (no)	2002-08-26
CZ283968B6 (cs)	1998-07-15
EP0796618B1 (de)	2002-01-30
AU1628597A (en)	1997-09-25
KR19980023975A (ko)	1998-07-06

Publication	Publication Date	Title
PL304649A1 (en)	1995-02-20	Novel derivatives of taxane and pharmaceutical agents
EP0908186A3 (de)	1999-04-21	Verfahren zur Schmerzbehandlung
PT796618E (pt)	2002-06-28	Tratamento e profilaxia da pancreatite
FI905531A0 (fi)	1990-11-08	Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
DK0842934T3 (da)	2004-03-08	5-HT1F agonister
DE69331774D1 (de)	2002-05-08	7-Substituierte-8-substituierte-9-substituierte Amino-7-Demethyl-6-Deoxy-Tetracycline als antibiotische Mittel
MA23603A1 (fr)	1996-04-01	Derives d'oxalylamino-benzafuranne et benzothienyle.
DE69808620D1 (de)	2002-11-14	Universell verwendbares bluttplasma
KR910019620A (ko)	1991-12-19	15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
DE69825605D1 (de)	2004-09-16	Behandlung der schizophrenie und der psychose
NL194693B (nl)	2002-08-01	Werkwijze voor het bereiden van medicinale preparaten voor het behandelen van diabetes.
ID25478A (id)	2000-10-05	Agonis 5-ht1f
TR199600117A2 (tr)	1996-10-21	Ikame edilen benzolsülfonilüre ve tiyoüre, bu maddelerin elde edilmesi ve eczanecilikle ilgili maddelerin bu bilesimler ve bu bilesimleri iceren iyilestirici maddelere dayanarak kullanilmasi ile ilgili usul.
NO973003D0 (no)	1997-06-27	Synergistiske kombinasjoner av 2-(tiocyanometyltio)benzotiazol- og -tiofanatforindelser anvendelige som fungicider
DK453387A (da)	1988-02-29	Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation
ID20165A (id)	1998-10-15	Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
MX9704035A (es)	1998-02-28	1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
IT1303621B1 (it)	2000-11-15	Nastro trasportatore per il trattamento di materiali.
NO985550D0 (no)	1998-11-27	FremgangsmÕte for fremstilling av 2,2'-(1-metyl-1,2-etandiyliden)bis(hydrazinkarboksimidamid)
NO985551D0 (no)	1998-11-27	FremgnagsmÕte for fremstilling av 2,2'-(1-metyl-1,2-etandiyliden)bis(hydrazinkarboksimidamid)
DK1133297T3 (da)	2003-11-24	Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
ATE262527T1 (de)	2004-04-15	Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate
GR3036968T3 (en)	2002-01-31	Adamantyl substituted oxindoles as pharmaceutical agents
ZA971413B (en)	1997-08-21	Novel substituted n-methyl-n-(4-(piperindin-1-yl)-2(aryl) butyl)benzamines useful for the treatment of allergic diseases.
ITRM960407A0 (it)	1996-06-10	Procedimento per il trattamento di materiali contenenti amianto.